ArticleAnnals of medicine2023

Ipatasertib, an oral AKT inhibitor, in combination with carboplatin exhibits anti-proliferative effects in uterine serous carcinoma.

Wesley C Burkett et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.